In one paragraphArticle in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Raffaele PalmirottaInterdisciplinary Department of Medicine, School of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0002-9401-7377 Canio MartinelliSbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Department of Biology College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.ORCID 0000-0002-0587-8467 Alessandra MiceraResearch and Development Laboratory for Biochemical, Molecular and Cellular Applications in Ophthalmological Sciences, IRCCS-Fondazione Bietti, 00184 Rome, Italy.
Luciano GiacòBioinformatics Core Facility, Gemelli Science and Technology Park (G-STeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.ORCID 0000-0003-0657-4323 Federica PersianiBioinformatics Core Facility, Gemelli Science and Technology Park (G-STeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.ORCID 0009-0006-8280-2059 Andrea MorrioneSbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Department of Biology College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.ORCID 0000-0002-2319-7884 Cosimo PastoreMedical Oncology, SG Moscati Hospital, 74010 Statte, Italy.
Claudia NisiMedical Oncology, SG Moscati Hospital, 74010 Statte, Italy.
Gabriella ModoniMedical Oncology, SG Moscati Hospital, 74010 Statte, Italy.
Teresa GaleanoMedical Oncology, SG Moscati Hospital, 74010 Statte, Italy.
Tiziana GuarinoMedical Oncology, SG Moscati Hospital, 74010 Statte, Italy.
Ilaria FoggettiMedical Oncology, SG Moscati Hospital, 74010 Statte, Italy.
Cecilia NisticòMedical Oncology Unit, ASL Frosinone, 03100 Frosinone, Italy.
Antonio GiordanoSbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Department of Biology College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.ORCID 0000-0002-5959-016X Salvatore PiscontiMedical Oncology, SG Moscati Hospital, 74010 Statte, Italy.
Funding
by Fondazione Roche per I Pazienti, Bando 2020 "Accanto a chi si prende cura". ND
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antineoplastic AgentsCarcinoma, Non-Small-Cell LungDrug-Related Side Effects and Adverse ReactionsLung NeoplasmsPharmacogeneticsAdultAgedFemaleHumansMaleMiddle AgedPolymorphism, Single NucleotideAntineoplastic Agentscancerindividual variabilityoncologypersonalized medicinepharmacogeneticspharmacogenomicssupportive caresymptom management
Identifiers
PMID40149417
PMCPMC11942520
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390